A recent SEC filing revealed that tech billionaire Peter Thiel and related entities acquired a 7.5% stake in 180 Life Sciences, now known as "ETHZilla," causing the company's stock to triple in value. Thiel's involvement in crypto extends to various ventures, including Ethereum-focused companies like BitMine.